Thermo Fisher Scientific (TMO) Enterprise Value (2009 - 2026)

Thermo Fisher Scientific has reported Enterprise Value for 18 years, with the latest figure at -$3.9 billion in Q2 2026.

• Enterprise Value for Q2 2026 came in at -$3.9 billion, up 37.05% year-over-year; the trailing twelve-month figure through Jun 2026 was -$3.9 billion (up 37.05% YoY), and the FY2025 annual result was -$10.0 billion, down 83.17% from the prior year.
• Enterprise Value fell to -$3.9 billion in Q2 2026, from -$3.1 billion in the prior quarter.
• Over five years, Enterprise Value peaked at -$1.8 billion in Q3 2022 and troughed at -$10.0 billion in Q4 2025.
• A 5-year average of -$5.4 billion and a median of -$5.6 billion in 2024 frame the typical range for Enterprise Value.
• The widest annual swing landed in 2022, when Enterprise Value soared 76.72%; it then tumbled 188.34% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$8.4 billion in 2022, then gained by 5.3% to -$8.0 billion in 2023, then soared by 31.55% to -$5.4 billion in 2024, then slumped by 83.17% to -$10.0 billion in 2025, then soared by 60.5% to -$3.9 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$3.9 billion in Q2 2026, -$3.1 billion in Q1 2026, and -$10.0 billion in Q4 2025.